期刊文献+

明胶、阿拉伯胶复合凹土制备乳酸菌微胶囊研究 被引量:1

Study on Lactobacillus microcapsule prepared by gelatin,acacia and attapulgite
下载PDF
导出
摘要 本试验以载菌凹土作为芯材,以明胶、阿拉伯胶复合凹土作为壁材,制备乳酸杆菌微胶囊。结果表明,当菌胶比为1∶8,明胶、阿拉伯胶总用量为4%,比例为1∶1,复合0.4%的凹土,添加固化剂,在p H 3.9时于25℃固化10 min,包埋率最高可达93.6%。该微胶囊经离心收集、冷冻干燥后,在人工胃肠液环境中研究其抗逆环境能力,结果表明,该微胶囊活菌制剂在胃环境中的释放率与游离乳酸杆菌、载菌凹土接近,并在肠环境中能较好地保持活菌比例。证明明胶、阿拉伯胶复合凹土壁材对于乳酸菌具有较好的保护作用。 In this test,Lactobacillus microcapsule was prepared by using attapulgite carried probiotic as the core mate- rial,and gelation and acacia were used as the wall material.The resuhs showed that when the ratio of attapulgite carried lac- tobacillus and gum was 1:8,the concentration of compound gum was 4%,the ratio of glutin and acacia was 1:1 ,the concen- tration of attapulgite was 0.4% ,pH was 3.9,reacted at 25 ℃ for 10 min,the embedding rates of the microcapsules were 93.6%.The microcapsules were collected by centrifugaiton,frozen and dried.The antiadverse environmental capacity of the probiotics product was studied in the artificial gastrointestinal fluid.The results showed that the releasing rate of living lacto- bacillus was roughly the same as the free lactobacillus and the attapulgite carried probiotic,but the living cells could main- tain in the intestinal environment for long time.The results was proved that the composite wall material of gelatin, acacia and attapulgite had good protective effect.
作者 冯云琪
出处 《中国饲料》 北大核心 2015年第23期34-37,共4页 China Feed
基金 江苏省科技支撑计划--农业部分"可替代抗生素的凹土基益生菌微胶囊饲料添加剂制备的关键技术研究"(BE2013357) 江苏省农业科技自主创新资金"兽用益生菌/纳米凹土复合免疫增强剂的研发"[CX(13)3068]
关键词 微胶囊 复合壁材 凹土 活菌制剂 microcapsule composit wall material attapulgite probiotics
  • 相关文献

参考文献6

二级参考文献64

  • 1宋焕禄,刘晋芳,吕跃钢.耶罗维亚酵母(Yarrowia lipolytica)发酵蓖麻油制备γ-癸内酯的研究[J].中国食品学报,2007,7(5):102-107. 被引量:4
  • 2苏畅,任大明,杜毅,陈洪,王小丰.微生物发酵法生产γ-癸内酯[J].食品工业科技,2004,25(10):118-119. 被引量:14
  • 3Norton PM, Le Page RWF, Wells JM. Progress in the de- velopment of Lactococcus lactis as a recombinant muco- sal vaccine delivery system[J]. Folia Microbiol (Praha), 1995, 40(3): 225-230.
  • 4O'Sullivan DJ, Walker SA, West SG, et al. Development of an expression strategy using a lytic phage to trigger explosive plasmid amplification and gene expression[J]. Biotechnology (NY), 1996, 14(1): 82-87.
  • 5Ribeiro LA, Azevedo V, Le Loir Y, et al. Production and targeting of the Brucella abortus antigen LT/L12 in Lac- tococcus lactis: a first step towards food-grade live vac- cines against brucellosis[J]. Appl Environ Microbiol, 2002, 68(2): 910-916.
  • 6Gilbert C, Robinson K, Le Page RWF, et al. Heterologous expression of an immunogenic pneumococcal type 3 cap- sular polysaccharide in Lactococcus lactis[J]. Infect Im- mun, 2000, 68(6): 3251-3260.
  • 7Steidler L, Robinson K, Chamberlain L, et al. Mucosal delivery of murine interleukin-2 (IL-2) and IL-6 by re- combinant strains of Lactococcus lactis coexpressing an- tigen and cytokine[J]. Infect Immun, 1998, 66(7): 3183-3189.
  • 8Schotte L, Steidler L, Vandekerckhove J, et al. Secretion of biologically active murine interleukin-10 by Lactococ- cus lactis[J]. Enzyme Microb Technol, 2000, 27(10): 761-765.
  • 9Bermfidez-Humarfin LG, Langella P, Cortes-Perez NG, et al. Intranasal immunization with recombinant Lactococcus lactis secreting murine interleukin-12 enhances anti- gen-specific Thl cytokine production[J]. Infect Immun, 2003, 71(4): 1887-1896.
  • 10Dave RI, Shah NR. Effect of level of starter culture on viability of yoghurt and probiotic bacteria in yoghurts[J]. Food Australia, 1997, 49: 164-168.

共引文献20

同被引文献8

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部